Thomas White International’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$4.89K Buy
11
+3
+38% +$1.38K ﹤0.01% 247
2023
Q1
$3.68K Hold
8
﹤0.01% 259
2022
Q4
$4.1K Hold
8
﹤0.01% 272
2022
Q3
$4K Hold
8
﹤0.01% 277
2022
Q2
$4K Hold
8
﹤0.01% 279
2022
Q1
$4K Hold
8
﹤0.01% 274
2021
Q4
$4K Hold
8
﹤0.01% 291
2021
Q3
$3K Hold
8
﹤0.01% 304
2021
Q2
$3K Hold
8
﹤0.01% 301
2021
Q1
$3K Sell
8
-700
-99% -$225K ﹤0.01% 301
2020
Q4
$227K Buy
+708
New +$217K 0.04% 244

Other funds holding ELV

Thomas White International's ELV Position: Q2 2023 in Review

Thomas White International increased its Elevance Health (ELV) stake by 38% in Q2 2023, buying an estimated $1.38K and bringing the position to 11 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Thomas White International first reported a position in ELV in Q4 2020 and has held it in 11 quarters since. The position peaked at $227K in Q4 2020. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Thomas White International held 11 shares of Elevance Health worth $4.89K as of Q2 2023.
  • Thomas White International bought 3 Elevance Health shares in Q2 2023, an estimated $1.38K.
  • Elevance Health made up ﹤0.01% of Thomas White International's portfolio in Q2 2023, its #247 holding.
  • Thomas White International first reported a position in Elevance Health in Q4 2020 and has held it in 11 quarters since.
  • Thomas White International's Elevance Health position peaked at $227K in Q4 2020.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Thomas White International's 13F filing for Q2 2023, filed 14 Aug 2023.